Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Rapid diagnostic testing for SARS-CoV-2 : Validation and comparison of three point-of-care antibody tests

Strand, Rasmus ; Thelaus, Louise LU ; Fernström, Nils ; Sunnerhagen, Torgny LU orcid ; Lindroth, Ylva LU ; Linder, Adam LU and Rasmussen, Magnus LU (2021) In Journal of Medical Virology 93(7). p.4592-4596
Abstract

With the emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a need for diagnostic tests has surfaced. Point-of-care (POC) antibody tests can detect immunoglobulin (Ig) G and M against SARS-CoV-2 in serum, plasma, or whole blood and give results within 15 min. Validation of the performance of such tests is needed if they are to be used in clinical practice. In this study, we evaluated three POC antibody tests. Convalescent serum samples from 47 reverse transcription-polymerase chain reaction (RT-PCR) verified patients with coronavirus disease 2019 (COVID-19) collected at least 28 days post RT-PCR diagnosis as well as 50 negative pre-COVID-19 controls were tested. The three tests (denoted the J-, N-, and Z-tests)... (More)

With the emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a need for diagnostic tests has surfaced. Point-of-care (POC) antibody tests can detect immunoglobulin (Ig) G and M against SARS-CoV-2 in serum, plasma, or whole blood and give results within 15 min. Validation of the performance of such tests is needed if they are to be used in clinical practice. In this study, we evaluated three POC antibody tests. Convalescent serum samples from 47 reverse transcription-polymerase chain reaction (RT-PCR) verified patients with coronavirus disease 2019 (COVID-19) collected at least 28 days post RT-PCR diagnosis as well as 50 negative pre-COVID-19 controls were tested. The three tests (denoted the J-, N-, and Z-tests) displayed the sensitivities of 87%, 96%, and 85%, respectively, for the detection of IgG. All tests had the same specificity for IgG (98%). The tests did not differ significantly for the detection of IgG. The sensitivities for IgM were lower (15%, 67%, and 70%) and the specificities were 90%, 98%, and 90%, respectively. The positive and negative predictive values were similar among the tests. Our results indicate that these POC antibody tests might be accurate enough to use in routine clinical practice.

(Less)
Please use this url to cite or link to this publication:
author
; ; ; ; ; and
organization
publishing date
type
Contribution to journal
publication status
published
subject
keywords
COVID-19, point-of-care test, SARS-CoV-2, sensitivity, specificity, validation
in
Journal of Medical Virology
volume
93
issue
7
pages
5 pages
publisher
John Wiley & Sons Inc.
external identifiers
  • scopus:85104335896
  • pmid:33666238
ISSN
0146-6615
DOI
10.1002/jmv.26913
language
English
LU publication?
yes
id
32fba28d-7081-476a-82f9-8f4e89569b8f
date added to LUP
2021-04-26 15:01:11
date last changed
2024-06-15 10:31:06
@article{32fba28d-7081-476a-82f9-8f4e89569b8f,
  abstract     = {{<p>With the emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a need for diagnostic tests has surfaced. Point-of-care (POC) antibody tests can detect immunoglobulin (Ig) G and M against SARS-CoV-2 in serum, plasma, or whole blood and give results within 15 min. Validation of the performance of such tests is needed if they are to be used in clinical practice. In this study, we evaluated three POC antibody tests. Convalescent serum samples from 47 reverse transcription-polymerase chain reaction (RT-PCR) verified patients with coronavirus disease 2019 (COVID-19) collected at least 28 days post RT-PCR diagnosis as well as 50 negative pre-COVID-19 controls were tested. The three tests (denoted the J-, N-, and Z-tests) displayed the sensitivities of 87%, 96%, and 85%, respectively, for the detection of IgG. All tests had the same specificity for IgG (98%). The tests did not differ significantly for the detection of IgG. The sensitivities for IgM were lower (15%, 67%, and 70%) and the specificities were 90%, 98%, and 90%, respectively. The positive and negative predictive values were similar among the tests. Our results indicate that these POC antibody tests might be accurate enough to use in routine clinical practice.</p>}},
  author       = {{Strand, Rasmus and Thelaus, Louise and Fernström, Nils and Sunnerhagen, Torgny and Lindroth, Ylva and Linder, Adam and Rasmussen, Magnus}},
  issn         = {{0146-6615}},
  keywords     = {{COVID-19; point-of-care test; SARS-CoV-2; sensitivity; specificity; validation}},
  language     = {{eng}},
  month        = {{07}},
  number       = {{7}},
  pages        = {{4592--4596}},
  publisher    = {{John Wiley & Sons Inc.}},
  series       = {{Journal of Medical Virology}},
  title        = {{Rapid diagnostic testing for SARS-CoV-2 : Validation and comparison of three point-of-care antibody tests}},
  url          = {{https://lup.lub.lu.se/search/files/119180175/Rapid_diagnostic_testing_for_SARS_CoV_2pdf.pdf}},
  doi          = {{10.1002/jmv.26913}},
  volume       = {{93}},
  year         = {{2021}},
}